Plasma microRNA panel for minimally invasive detection of breast cancer.
Over the last few years, circulating microRNAs (miRNAs) have emerged as promising novel and minimally invasive markers for various diseases, including cancer. We already showed that certain miRNAs are deregulated in the plasma of breast cancer patients when compared to healthy women. Herein we have...
Main Authors: | Katarina Cuk, Manuela Zucknick, Dharanija Madhavan, Sarah Schott, Michael Golatta, Jörg Heil, Frederik Marmé, Andrey Turchinovich, Peter Sinn, Christof Sohn, Hans Junkermann, Andreas Schneeweiss, Barbara Burwinkel |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3806790?pdf=render |
Similar Items
-
Evaluation of Promoter Methylation of RASSF1A and ATM in Peripheral Blood of Breast Cancer Patients and Healthy Control Individuals
by: Xue Cao, et al.
Published: (2018-03-01) -
Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures
by: Dharanija eMadhavan, et al.
Published: (2013-06-01) -
Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer: Clinical utility of the MD Anderson Prognostic Index.
by: Laura L Michel, et al.
Published: (2019-01-01) -
Circulating miRNAs: cell-cell communication function?
by: Andrey eTurchinovich, et al.
Published: (2013-06-01) -
The origin, function and diagnostic potential of extracellular microRNA in human body fluids
by: Andrey eTurchinovich, et al.
Published: (2014-02-01)